ADC (Antibody-Drug Conjugates)

Antibody-Drug Conjugates (ADCs) are advanced targeted cancer treatments that combine an antibody with a powerful chemotherapy drug. The antibody acts like a guided missile, recognizing and attaching to specific proteins on cancer cells. Once attached, the ADC delivers the toxic drug directly to the cancer cell, sparing most healthy cells. This targeted approach aims to improve treatment effectiveness and reduce side effects. ADCs are used for certain types of cancer and represent a precise way to attack tumors by harnessing the body's immune recognition system combined with potent chemotherapy.